“Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity” (2024) InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes, 1(2), pp. 96–110. Available at: https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12 (Accessed: 3 August 2025).